131 related articles for article (PubMed ID: 29173158)
1. Novel Insights into the Molecular Interaction of a Panduratin A Derivative with the Non Structural Protein (NS3) of Dengue Serotypes: A Molecular Dynamics Study.
Parida P; Yadav RNS; Dehury B; Ghosh D; Mahapatra N; Mitra A; Mohanta TK
Curr Pharm Biotechnol; 2017; 18(9):769-782. PubMed ID: 29173158
[TBL] [Abstract][Full Text] [Related]
2. Design, virtual screening and docking study of novel NS3 inhibitors by targeting protein-protein interacting sites of dengue virus - a novel approach.
Parida P; Yadav RN; Sarma K; Nainwal LM
Curr Pharm Biotechnol; 2013; 14(11):995-1008. PubMed ID: 24372240
[TBL] [Abstract][Full Text] [Related]
3. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
4. Insight into structural organization and protein-protein interaction of non structural 3 (NS3) proteins from dengue serotypes.
Parida P; Yadav RN; Sarma K
Curr Pharm Biotechnol; 2014; 15(2):156-72. PubMed ID: 24910013
[TBL] [Abstract][Full Text] [Related]
5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
[TBL] [Abstract][Full Text] [Related]
7. Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations.
Davidson RB; Hendrix J; Geiss BJ; McCullagh M
PLoS Comput Biol; 2018 Apr; 14(4):e1006103. PubMed ID: 29659571
[TBL] [Abstract][Full Text] [Related]
8. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
10. Design of new competitive dengue NS2B/NS3 protease inhibitors-a computational approach.
Frimayanti N; Chee CF; Zain SM; Rahman NA
Int J Mol Sci; 2011 Feb; 12(2):1089-100. PubMed ID: 21541045
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide-dependent dynamics of the Dengue NS3 helicase.
Sarto C; Kaufman SB; Estrin DA; Arrar M
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140441. PubMed ID: 32371149
[TBL] [Abstract][Full Text] [Related]
12. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
Hariono M; Choi SB; Roslim RF; Nawi MS; Tan ML; Kamarulzaman EE; Mohamed N; Yusof R; Othman S; Abd Rahman N; Othman R; Wahab HA
PLoS One; 2019; 14(1):e0210869. PubMed ID: 30677071
[TBL] [Abstract][Full Text] [Related]
13. Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis.
Xue W; Wang M; Jin X; Liu H; Yao X
Mol Biosyst; 2012 Oct; 8(10):2753-65. PubMed ID: 22833015
[TBL] [Abstract][Full Text] [Related]
14. Ethyl 4-(4-methylphenyl)-4-pentenoate from Vetiveria zizanioides Inhibits Dengue NS2B-NS3 Protease and Prevents Viral Assembly: A Computational Molecular Dynamics and Docking Study.
Lavanya P; Ramaiah S; Anbarasu A
Cell Biochem Biophys; 2016 Sep; 74(3):337-51. PubMed ID: 27324039
[TBL] [Abstract][Full Text] [Related]
15. Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.
Piccirillo E; Merget B; Sotriffer CA; do Amaral AT
J Comput Aided Mol Des; 2016 Mar; 30(3):251-70. PubMed ID: 26923377
[TBL] [Abstract][Full Text] [Related]
16. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.
Khan RA; Hossain R; Siyadatpanah A; Al-Khafaji K; Khalipha ABR; Dey D; Asha UH; Biswas P; Saikat ASM; Chenari HA; Wilairatana P; Islam MT
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833913
[TBL] [Abstract][Full Text] [Related]
17. Structural features of NS3 of Dengue virus serotypes 2 and 4 in solution and insight into RNA binding and the inhibitory role of quercetin.
Pan A; Saw WG; Subramanian Manimekalai MS; Grüber A; Joon S; Matsui T; Weiss TM; Grüber G
Acta Crystallogr D Struct Biol; 2017 May; 73(Pt 5):402-419. PubMed ID: 28471365
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
20. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
